Axio Biosolutions Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 143
Employees
  • Latest Deal Type
  • Series B2
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 7

Axio Biosolutions General Information

Description

Operator of a medical technology company intended to create active medical products to address health care needs such as surgical and wound care. The company's platform uses innovative medical technology to create breakthrough products for the management of trauma, surgical and chronic wounds and save lives, enabling patients to get products for wound care.

Contact Information

Website
www.axiobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Primary Office
  • Plot 18, Gujarat Pharma Techno Park
  • Sari-Matoda, Ta Sanand
  • Ahmedabad, Gujarat 382220
  • India
+91 088607 00000

Axio Biosolutions Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axio Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B2) 27-Jul-2021 $6M 000.00 0000 Completed Generating Revenue
5. Later Stage VC (Series B1) 08-Jan-2020 00.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 26-Jan-2018 00.00 00.00 000.00 Completed Product Development
3. Later Stage VC (Series A) 09-May-2016 00.00 00.000 00.00 Completed Product In Beta Test
2. Seed Round 01-Jan-2010 $190K $190K 00000 Completed Stealth
1. Grant 01-Jan-2009 $1M Completed Stealth
To view Axio Biosolutions’s complete valuation and funding history, request access »

Axio Biosolutions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series B1 0,000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series B 1,966,700 $0.000010 0.01% $3.73 $3.73 1x $3.73 31.64%
Series A 781,367 $0.000010 0.01% $2.69 $2.69 1x $2.69 12.57%
To view Axio Biosolutions’s complete cap table history, request access »

Axio Biosolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a medical technology company intended to create active medical products to address health care needs such as
Medical Supplies
Ahmedabad, India
143 As of 2021
000.00
000 0000-00-00
00000000000 000.00

00000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000000 00000000
Crewe, United Kingdom
00 As of 0000
000.00
0000000 0000 000.00

0-000000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
0000000 00000000
Wallingford, CT
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axio Biosolutions Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedTrade Products Private Equity-Backed Crewe, United Kingdom 00 000.00 0000000 0000 000.00
0-000000 Formerly PE-Backed Wallingford, CT 000 000000&0
000000 00000000000 Corporation Deerfield, IL 00000 000 00000000000 000
0000000 0000-00000 Corporation Blue Ash, OH 0000
To view Axio Biosolutions’s complete competitors history, request access »

Axio Biosolutions Patents

Axio Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3111091-A1 Composite dressings, manufacturing methods and applications thereof Pending 27-Aug-2018 000000000
EP-3843796-A1 Composite dressings, manufacturing methods and applications thereof Pending 27-Aug-2018 000000000
US-20210252182-A1 Composite dressings, manufacturing methods and applications thereof Pending 27-Aug-2018 000000000
AU-2019331721-A1 Composite dressings, manufacturing methods and applications thereof Pending 27-Aug-2018 000000000
EP-3534975-A1 Mucoadhesive preparations, methods and applications thereof Pending 04-Nov-2016 A61K9/006

Axio Biosolutions Executive Team (4)

Name Title Board Seat Contact Info
Leo Mavely Founder, Chief Executive Officer & Chairman
Gourav Maheshwari Director, Finance & Board Member
You’re viewing 2 of 4 executive team members. Get the full list »

Axio Biosolutions Board Members (6)

Name Representing Role Since
Badri Bahukutumbi Omidyar Network Board Member 000 0000
Barath Subramanian Accel Board Member 000 0000
Gourav Maheshwari Axio Biosolutions Director, Finance & Board Member 000 0000
Leo Mavely Axio Biosolutions Founder, Chief Executive Officer & Chairman 000 0000
Ranjith Menon Chiratae Ventures India Advisors Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Axio Biosolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axio Biosolutions Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TrueScale Capital Venture Capital Minority 000 0000 000000 0
Omidyar Network Impact Investing Minority 000 0000 000000 0
University of California SBIC Minority 000 0000 000000 0
RNT Associates Venture Capital Minority 000 0000 000000 0
Accel Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »